Literature DB >> 26921872

Targeted genome engineering using designer nucleases: State of the art and practical guidance for application in human pluripotent stem cells.

Sylvia Merkert1, Ulrich Martin2.   

Abstract

Within the last years numerous publications successfully applied sequence specific designer nucleases for genome editing in human PSCs. However, despite this abundance of reports together with the rapid development and improvement accomplished with the technology, it is still difficult to choose the optimal methodology for a specific application of interest. With focus on the most suitable approach for specific applications, we present a practical guidance for successful gene editing in human PSCs using designer nucleases. We discuss experimental considerations, limitations and critical aspects which will guide the investigator for successful implementation of this technology.
Copyright © 2016 University of Texas at Austin Dell Medical School. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Human pluripotent stem cells; TALEN; ZFN

Mesh:

Substances:

Year:  2016        PMID: 26921872     DOI: 10.1016/j.scr.2016.02.027

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  9 in total

1.  Ex vivo Generation of Genetically Modified Macrophages from Human Induced Pluripotent Stem Cells.

Authors:  Mania Ackermann; Alexandra Kuhn; Jessica Kunkiel; Sylvia Merkert; Ulrich Martin; Thomas Moritz; Nico Lachmann
Journal:  Transfus Med Hemother       Date:  2017-05-16       Impact factor: 3.747

Review 2.  CRISPR/Cas9 facilitates genomic editing for large-scale functional studies in pluripotent stem cell cultures.

Authors:  Xiao-Fei Li; Yong-Wei Zhou; Peng-Fei Cai; Wei-Cong Fu; Jin-Hua Wang; Jin-Yang Chen; Qi-Ning Yang
Journal:  Hum Genet       Date:  2019-10-12       Impact factor: 4.132

3.  New Human Chromosomal Sites with "Safe Harbor" Potential for Targeted Transgene Insertion.

Authors:  Stefan Pellenz; Michael Phelps; Weiliang Tang; Blake T Hovde; Ryan B Sinit; Wenqing Fu; Hui Li; Eleanor Chen; Raymond J Monnat
Journal:  Hum Gene Ther       Date:  2019-03-28       Impact factor: 5.695

4.  Optimization of trans-Splicing for Huntington's Disease RNA Therapy.

Authors:  Hansjörg Rindt; Colton M Tom; Christian L Lorson; Virginia B Mattis
Journal:  Front Neurosci       Date:  2017-10-10       Impact factor: 4.677

Review 5.  Editing the genome of hiPSC with CRISPR/Cas9: disease models.

Authors:  Andrew R Bassett
Journal:  Mamm Genome       Date:  2017-03-16       Impact factor: 2.957

6.  Successful CRISPR/Cas9 mediated homologous recombination in a chicken cell line.

Authors:  Ekaterina Antonova; Olga Glazova; Anna Gaponova; Aykaz Eremyan; Svetlana Zvereva; Natalya Grebenkina; Natalya Volkova; Pavel Volchkov
Journal:  F1000Res       Date:  2018-02-28

7.  Designing A Transgenic Chicken: Applying New Approaches toward A Promising Bioreactor.

Authors:  Salahadin Bahrami; Amir Amiri-Yekta; Abbas Daneshipour; Seyedeh Hoda Jazayeri; Paul Edward Mozdziak; Mohammad Hossein Sanati; Hamid Gourabi
Journal:  Cell J       Date:  2019-10-14       Impact factor: 2.479

8.  Germline Gene Editing in Chickens by Efficient CRISPR-Mediated Homologous Recombination in Primordial Germ Cells.

Authors:  Lazar Dimitrov; Darlene Pedersen; Kathryn H Ching; Henry Yi; Ellen J Collarini; Shelley Izquierdo; Marie-Cecile van de Lavoir; Philip A Leighton
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 9.  Site-Specific Genome Engineering in Human Pluripotent Stem Cells.

Authors:  Sylvia Merkert; Ulrich Martin
Journal:  Int J Mol Sci       Date:  2016-06-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.